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Local anesthesia has been defined as a loss of sensation in an area of 
the body caused by a depression of excitation in nerve endings or an inhibition of 
the conduction process in peripheral nerves (Covino & Vassallo 1976).  Local 
anesthetic solutions have been utilized in clinical dentistry to alleviate or 
eliminate pain associated with invasive procedures as early as the 19th century 
(Malamed 2004).  An important requirement prior to initiating endodontic or 
operative dental treatment is the ability to achieve and maintain profound 
anesthesia.  Local anesthetics are correctly considered to be the most important 
drugs used in clinical dentistry.  Unlike the majority of other anesthetic drugs, 
which act as central nervous system depressants, local anesthetics prevent 
nociceptive impulses from reaching the central nervous system by blocking the 
progress of an action potential.  A local anesthetic binds to sodium channel 
receptors on the axonal membrane, the permeability to sodium ions is lost and 
nerve conduction is interrupted (Malamed 2004). 
Dentists currently have a variety of anesthetic solutions at their disposal, 
with the major difference being their expected duration of clinical anesthesia 
(Table 1.1).  Although these solutions are considered to be generally effective in 
providing a pain free oral environment for dental treatment, local anesthetic 
failure remains a common problem in certain instances. Clinicians have 
constantly sought an anesthetic solution that may improve success rates that 
have been demonstrated to be well below one-hundred percent, particularly in 
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the posterior mandible (Robertson et al. 2007, Claffey et al. 2004, P. Mikesell et 




In the U.S., lidocaine has been the most widely used anesthetic solution 
for sometime (Malamed et al. 2000).  Since it became clinically available in 1948 
it has been associated with efficacy and a low incidence of side effects (Malamed 
2004).  These attributes have been confirmed through clinical use and research 
making it the “gold standard” to which all new local anesthetic solutions are 
compared (Malamed 2004).  The recent U.S. Food and Drug Administration 
approval of articaine (NDA # 20-971) and the possibility that it will provide 
increased efficacy has already caused this drug to be a popular choice in place 
of lidocaine among clinicians especially endodontists who commonly treat 
inflamed teeth.  This solution made up approximately 25% of total sales of dental 
anesthetics in the U.S. in 2007, second only to lidocaine at 54% (Pogrel 2007).  
Articaine was approved by the FDA for use in the U.S. in April 2000 but 
has been available in Germany and other European nations since 1969, and is 
currently the most widely used solution there (Malamed et al. 2000).  In the U.S. 
the formulation is marketed under the trade names Septocaine! (Septodont, 
France) and Articadent! (Novocol Pharmaceutical of Canada, Inc) and is 
available as a 4% solution with 1:100,000 or 1:200,000 epinephrine.  Articaine 
contains a thiophene ring instead of a benzene ring found in lidocaine and other 
amide local anesthetics, which allows the molecule to diffuse more readily 
through the nerve membrane due to increased lipid solubility.  A second 
molecular difference is the extra ester linkage incorporated into the articaine 
molecule which results in hydrolysis of articaine by plasma esterases.  Ninety to 
ninety-five percent of articaine is metabolized by plasma esterases, with the 
remainder being broken down in the liver (Oertel et al. 1997).  The solution’s 
plasma half-life can be as low as 20 minutes (Oertel et al. 1997).  Articaine is 
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excreted mainly by the kidneys. From an epidural dose 2 to 5% is excreted 
unchanged; 40 to 70% is excreted as articainic acid and 4 to 15 % as articainic 
acid glucuronide (Vree et al. 1988). 
The recommended maximum dose of articaine is 500 mg similar to that 
advised for lidocaine (Malamed 2004). Adverse reactions to articaine are 
characteristic of those associated with other amide-type anesthetics (Malamed et 
al. 2000).  For a healthy adult weighing 70 kg, this maximum dose equates to 
seven 1.8 mL carpules of 4% articaine, or 13 of 2% lidocaine (Oertel et al. 1997).  
As with other amide local anesthetics, articaine is capable of producing 
methemoglobinemia. However, this has thus far been observed only with 




The success of mandibular block anesthesia has traditionally been 
determined by the presence of a feeling of “lip numbness” (Malamed 2004).  It 
was thought that if soft tissue anesthesia was present, indicated by a lack of 
mucosal responsiveness to a sharp instrument, pulpal anesthesia would also be 
adequate.  However, a number of studies have now clarified that successful 
pulpal anesthesia is not guaranteed when signs of soft tissue anesthesia are 
present (Hannan et al. 1999, Certosimo & Archer 1996).  An investigation 
utilizing ultrasound to accurately locate the inferior alveolar neurovascular bundle 
found success rates ranged from 38% to 92%, although every patient did 
experience subjective lip anesthesia (Hannan et al. 1999). 
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Due to the unreliability of correlating soft tissue anesthesia with true 
pulpal anesthesia, a more objective method of measurement would be preferred.  
The electric pulp tester (EPT) has long been used to evaluate the sensibility of 
the dental pulp (Cooley et al. 1984).  This device stimulates A-delta fibers, 
normally indicating neural transmission and presence of innervation (Närhi et al. 
1979).  An EPT reading of “80” on the device most commonly used (Analytic 
Technologies Corp, Redmond, WA) indicates profound pulpal anesthesia 
(Dreven et al. 1987, Certosimo & Archer 1996).  EPT readings of less than 80 
have been correlated with pain during operative procedures in asymptomatic 
teeth (Certosimo & Archer 1996).  Currently, most investigations interested in 
determining pulpal anesthesia utilize the EPT method.  Successful anesthesia is 
commonly defined as the percentage of subjects who achieve two consecutive 
“80” readings on the EPT within 15 minutes of anesthesia administration, and 
continuously sustain this lack of responsiveness for some defined period (Evans 
et al. 2008, Corbett et al. 2008). These criteria help remove some of the 
subjectivity in assessing pulpal anesthesia, although the evaluation still relies on 
a patient’s response.  The behavior of the patient and the responses given by 
control teeth also should require careful consideration (Lin & Chandler 2008).  
Using the EPT as a more objective means of determining pulpal anesthesia has 
been useful in improving the clarity of research outcomes in the area of local 
anesthesia in dentistry. 
 
Evaluating the efficacy of local anesthetics is more uncertain in 
symptomatic teeth.  Effectively anesthetizing a tooth that contains an acutely 
inflamed pulp is often difficult.  Success rates for traditional anesthesia methods 
drop to unacceptable levels (Claffey et al. 2004, Srinivasan et al. 2009).  Using 
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the EPT to determine the efficacy of pulpal anesthesia is unreliable.  The 
absence of a response to EPT may not guarantee profound pulpal anesthesia 
(Dreven et al. 1987, Hsiao-Wu et al. 2007).  Several explanations for the failure 
of anesthetic solutions in such patients are present in the literature.  Nerves in 
inflamed tissues have reduced excitability thresholds (Byers et al. 1990).  It has 
also been noted that certain classes of sodium channels are resistant to the 
action of local anesthetics.  A class of tetrodotoxin-resistant sodium channels (Na 
v 1.8 and 1.9) have been shown to be resistant to the measures of local 
anesthetics (Roy & Narahashi 1992).   These channels are up-regulated during 
inflammation, and are thought to contribute to instances of orofacial hyperalgesia 
(Morgan & Gebhart 2008).  Additionally, pulps that have been diagnosed with 
irreversible pulpitis may have an increased expression of sodium channels 
(Malamed 2004).  These findings help explain why dental patients who present 
with pain from pulpal disease may have be difficult to anesthetize. 
Clinical studies of various designs have investigated the efficacy of local 
anesthetic solutions in clinical dentistry.  The conclusions of several recent 
clinical studies suggest that articaine may be more effective than lidocaine. One 
prospective, randomized, double-blind study reported that the use of 4% articaine 
with 1:100,000 epinephrine resulted in a higher success rate and faster onset of 
anesthesia than 2% lidocaine with 1:100,000 epinephrine (Robertson et al. 
2007).  A similar study supported articaine’s superiority to lidocaine when used in 
a buccal infiltration technique (Kanaa, et al. 2006). 
Other clinical evidence has indicated that articaine may not outperform 
lidocaine.  Controlled comparisons of mandibular block anesthesia have failed to 
show any difference between articaine and lidocaine solutions.  Unacceptable 
rates of success for both articaine and lidocaine when used for mandibular block 
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injections have been demonstrated for patients who had been diagnosed with 
irreversible pulpitis (24 and 23 % success rates, respectively) (Claffey et al. 
2004).  Other studies have also concluded that there were no significant 
differences between articaine and lidocaine solutions when used for inferior 
alveolar nerve blocks (P. Mikesell et al. 2005).  The lack of consensus can be 
reached in regard to the clinical efficacy of articaine anesthetic solutions supports 
the need for a thorough review of available clinical data, and the formulation of 
recommendations regarding the appropriate use of local anesthetics in clinical 
dentistry. 
Maxillary infiltration has a higher rate of success than mandibular 
anesthesia.  Using a volume of 3.6 mL or less and various anesthetic 
formulations, pulpal anesthetic success has ranged from 64% to 100% for 
maxillary infiltrations (Vähätalo et al. 1993, Donaldson et al. 1987, Costa et al. 
2005). 
When focusing on the maxilla, clinical trials have repeatedly failed to 
show that articaine is superior to lidocaine or prilocaine in obtaining pulpal 
anesthesia with a maxillary infiltration (Donaldson et al. 1987, Vähätalo et al. 
1993).  Yet other studies contradict these findings.  It has been reported that the 
use of articaine resulted in a longer duration of anesthesia in maxillary 
infiltrations than lidocaine (Costa et al. 2005).  To add to the ambiguity one 
randomized, double-blind clinical study demonstrated a higher rate anesthetic 
success for articaine when compared with lidocaine in maxillary infiltration of the 
lateral incisor, but not the first molar (Evans et al. 2008).  This lack of a clear 
conclusion provides a strong rationale for conducting a systematic review.of the 
available literature. 
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Clinicians’ conclusions regarding their preference of local anesthetics are 
also influenced by lower levels of evidence, such as expert opinions.  Malamed, 
a well-known scientist who routinely lectures on the topic of local anesthesia in 
dentistry, submitted the first articaine study originating in the U.S. to the Journal 
of the American Dental Association in 2000.  This report stated that the newly 
FDA approved solution of articaine would provide improved local anesthetic 
activity (Malamed et al. 2000).  The study reported superior qualities including 
more success in achieving anesthesia, the ability to achieve more rapid and 
profound anesthesia, the success of buccal infiltration in the maxilla to achieve 
palatal anesthesia, and the success of mandibular infiltration to replace inferior 
alveolar block anesthesia (Malamed et al. 2000). 
Other opinions have contributed to a belief in the superior efficacy of 
articaine.  In a 2001 a report from Clinical Research Associates, a majority of 94 
dentist surveyed stated that articaine’s effects were more profound than other 
routinely used anesthetic solutions (Christensen 2001).  Many clinicians who 
have adopted the use of articaine agreed that its use seemed to offer an 
increased profoundness of anesthesia compared to other solutions. However, the 




The use of local anesthetics in dentistry has historically been 
accompanied by a very low risk of complications, although current evidence 
suggests that with some specific solutions the risk may be increased.  Several 
retrospective studies state that the fear of increased risk of paresthesia with 
articaine is warranted. In an investigation of 52 incidences of paresthesia in 
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Denmark, Hillerup and Jensen reported that 54% of the nerve injuries were 
associated with the use of articaine (Hillerup & Jensen 2006).  The authors 
concluded that “during the two-year period mentioned, articaine produced a more 
than 20-fold higher incidence of injection injury when applied for mandibular 
block anesthesia”.  A retrospective analysis of paresthesia after local anesthetic 
administration for non-surgical dental procedures over a 20 year period also 
revealed a higher than expected frequency of paresthesia with articaine (Haas & 
Lennon 1995).  An even more recent retrospective review of reported 
paresthesias from 1999 to 2008 reported that higher concentration solutions such 
as articaine were associated with significantly greater frequencies of such 
complications (Gaffen & Haas 2009). 
Contradictory data suggest that articaine is just as safe as other 
anesthetic solutions.  Malamed stated that “there is absolutely no scientific 
evidence available to support the claim that articaine is associated with a greater 
incidence of paresthesia than other local anesthetics” (Malamed 2007).  
Additionally, Clinical Research Associates released two reports of paresthesia in 
13,000 patient treatments with articaine (Christensen 2001).  A review of 
Septodont’s FDA application indicated that there were 21 paresthesias in 882 
patient treatments (2.4%), a frequency similar to that reported for lidocaine.  A 
2007 study by Pogrel reported that lidocaine was used in 35% of cases in which 
there was permanent nerve injury and articaine in 30% of the cases (Pogrel 
2007). 
The belief among practitioners that articaine has improved efficacy when 
compared with other solutions has reached a near consensus level (Overman 
2007).  The concern over an increased risk of paresthesia with the use of 
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articaine for mandibular block anesthesia is nearly as common (Wynn et al. 
2003, Dower 2003). 
There is still a very active dialogue among dentists regarding articaine’s 
safety, which can be seen on web-based discussion forums such as 
www.dentaltown.com, and in frequent letters to the journals of numerous local 
and national dental associations (Malamed 2007, Dower 2007).  Searching for 
the word “paresthesia” on Dentaltown’s online message board results in 544 
original discussion forums on the topic (www.towniecentral.com/MessageBoard/Search).  
Empirical evidence indicates that some local anesthetics including articaine, have 
a significantly higher rate of paresthesia associated with their use than others. A 
February 2003 issue of Dentistry Today contained an article that recommended 
that articaine not be used for mandibular block anesthesia, and that informed 
consent should be obtained if articaine is to be used for such injections (Dower 
2003). 
Allergenicity is also a concern with local anesthetic solution in dentistry.  
Historically, the most common ester-type anesthetics such as novocaine and 
procaine have been removed from the U.S. market because of occurrences of 
allergic reactions.  Local anesthetic solutions defined as ‘esters’ are derivatives 
of para-aminobenzoic acid (PABA), and hydrolysis liberates a moiety that may be 
immunogenic (Becker & Reed 2006).  Articaine and lidocaine are classified as 
amide local anesthetics because of the linkage between their lipid-soluble rings 
and terminal amines.  However, concern with the presence of PABA-related 
compounds in articaine local anesthetic solutions caused scrutiny by the FDA.  
Only after the U.S. composition was altered to not contain PABA-related 
compounds was articaine approved for therapeutic use in the U.S, despite its 





With such apparently divergent data on the safety and efficacy of using 
articaine as a local anesthetic solution it is not surprising that a wide range of 
opinions exists among dentists regarding the appropriateness of its use in clinical 
practice.  Evidence-based practice seeks to assess the quality of evidence 
relevant to the risks and benefits of treatments. The Centre for Evidence-Based 
Medicine defines “evidence-based medicine” as “the conscientious, explicit, and 
judicious use of current best evidence in making decisions about the care of 
individual patients” (Sackett et al. 1996).  In instances where the level of 
evidence supporting the use of a therapy appears unclear, techniques such as a 
systematic review of the literature should be applied to better clarify 
recommendations for clinical practice. 
Systematic reviews can condense many studies into valid and unbiased 
summaries of the best available evidence for a specific clinical problem (Carr 
2002).  This type of overview should benefit clinicians who have difficulty staying 
current as the literature greatly expands. Systematic reviews of the existing 
literature can provide an objective summary of the best available evidence that 
can help dentists and their patients make informed choices (Needleman 2002).   
By using explicit and transparent methods to perform a thorough literature 
search, systematic reviews are inherently less biased, more reliable, and more 
valid than narrative reviews (Carr 2002).  During the past 14 years, clinically 
relevant systematic reviews have been published with increasing frequency 
(Bader & Ismail 2004).  As the number of systematic reviews continues to grow, 
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dentistry will become better informed about the foundation of scientific evidence 
that directs evidence-based clinical practice (Bader & Ismail 2004). 
Systematic reviews do however have some limitations.  The quality of the 
underlying studies, the consistency of results across studies and the precision of 
the pooled data can considerably affect the strength of inference obtained 
(Torabinejad & Bahjri 2005).  Clinical practitioners need to recognize these 
inherent limitations, understand the results, and apply them judiciously to patient 
care. 
A systematic review may be even more valuable when partnered with a 
meta-analysis of the collected data.  Meta-analysis is the statistical pooling of 
data across studies to generate pooled estimates of effects (Manchikanti et al. 
2009).  Benefits of meta-analysis include the ability to improve the power of small 
studies to answer questions, and can also help detect biases and deficiencies in 
the design, analysis, and interpretation of research (Ioannidis 2008).  These 
methods can highlight needed improvements in the quality of the data needed for 
optimal evidence-based clinical practice.  In this way, meta-analysis can be a 
useful tool in planning new clinical trial in areas where the evidence is sparse. 
Because of the rather contradictory data regarding both the efficacy and 
safety of using articaine for local anesthesia, the objective of the present review 
is to evaluate the available information and provide reliable evidence regarding 
the use of articaine in the context of current local anesthetic solutions used in 
dentistry.  All clinical trials regarding the use of local anesthetics in dentistry that 
meet the developed inclusion criteria will be analyzed.  Clinical recommendations 









(1) To systematically review available evidence on the efficacy of local anesthetic 
solutions used for local anesthesia in clinical dentistry.   
(2) To compare the outcomes, benefits, and harms of using the available 
anesthetic solutions to provide pulpal anesthesia required for dental treatment.   
(3) To statistically analyze available data via meta-analytic approaches to 











As previously mentioned, there has been no clear consensus on which 
local anesthetic solutions should be expected to provide the highest rate of 
success.  Numerous publications have discussed topics regarding local 
anesthesia in clinical dentistry. In searching the Medline database for the 
previous twenty years, a total of 65 review articles are present that cover such 
subject matter.  However, only one article adhered to the methods of a 
systematic review.  This study investigated the effects of epinephrine in 
combination with local anesthetic solutions on dental patients that were 
previously diagnosed with hypertension (Bader et al. 2002). Another focused 
literature search aimed to compare the anesthetic efficacy of articaine and 
lidocaine, although it cannot be defined as a systematic review (Wells & Beckett 
2008). The remainder of the review papers could potentially contain bias, and 
must be classified as expert opinions, or a Level 5 source of evidence according 
to Sackett and colleagues (Sackett et al. 1996). 
Five of the reviews describe the use of local anesthetic solutions for the 
purpose of anesthesia during surgical procedures (Krohner 2003), including 
considerations for patients that are pregnant (Crowley 2007), obese (Todd 2005), 
children (Meechan & Welbury 1993),  and those undergoing orthognathic surgery 
(Weaver 1992).  Four articles cover topics that could be classified under the 
discipline of periodontics (Wilson et al. 2008, Kumar & Leblebicioglu 2007) 
Overman 2007, Higgins 1999). An additional four reviews discuss local 
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anesthetic use in pediatric populations (Ram & Peretz 2002, Saxen et al. 1999) 
Giovannitti 1995, Cheatham & Primosch 1991), and two specifically cover 
anesthetic considerations for patients in need of endodontic treatment (Saxen & 
C. W. Newton 1999, Haas 1997). 
Topical anesthetic compounds are exclusively described in two 
publications (Kravitz 2007, Meechan 2002) and one reviews the basic biology 
and pharmacology of local anesthetic solutions (Subramaniam & Tennant 2005).  
The possibility of adverse events and complications following the administration 
of local anesthetics in dentistry are detailed in a total of seven articles (Haas 
2006, Smith & Lung 2006, Finder & Moore 2002, Chen 1998, Haas 1998, 
Meechan & Rood 1997, Dower 2003).  Various techniques and anatomical 
considerations are described in eleven publications (Dower & Barniv 2004, 
Blanton & Roda 1995, Blanton & Jeske 2003, Meechan 2002, McKissock & 
Meyer 2000, R Brown 1999, Kretzschmar & Peters 1997, Yap & Ong 1996, van 
der Bijl 1995, Gross 1991, Donkor et al. 1990). The remaining twenty-nine 
papers discuss various general matters of local anesthetic use in clinical dentistry 
(Jeske & Blanton 2006, Brown & Rhodus 2005, Ramacciato & Meechan 2005, 
Yagiela 2004, Blanton & Jeske 2003, Budenz 2003,  Blanton & Jeske 2003, 
Hawkins & Moore 2002, Haas 2002, Wong 2001, Friedman 2000, Meechan 
2000, Potocnik & Bajrovi! 1999, Leyman et al. 1999, Estafan 1998,  Blanton & 
Jeske 2003, Brown 1994, Blanton & Jeske 2003, Blanton & Roda 1995, Roda & 
Blanton 1994, Malamed 1993, Hersh 1993, Anderson & Reagan 1993, Sisk 
1992, MacKenzie & Young 1993, Ayoub & Coleman 1992, Malamed et al. 1992, 






No previous publication has systematically reviewed the existing literature 
to summarize the current best evidence regarding the success rates of local 











The PICO (Patient Population, Intervention, Comparison, and Outcomes) 
process is a technique used in evidence-based medicine to frame and answer a 
clinical question.  It has been stated that a trend towards higher precision of 
search results when a PICO template was used, thus improving the relevancy of 
search results (Schardt et al. 2007).   
 
Defining the Scope of the Question 
The questions addressed by a systematic review may be both broad or 
narrow in scope, both of which have advantages and disadvantages.  Adopting a 
broad scope may allow for a more comprehensive summary of the evidence, 
provide the ability to assess generalizability of findings across different 
implementations of the intervention or types of participants.  However, searching, 
data collection, analysis, and writing may require more resources, and 
interpretation may be difficult if a high degree of heterogeneity is present.  A 
narrow scope has the advantage of manageability for the review team and 
improved clarity of objections, although evidence may be sparse and findings 
may not be generalizable. 
In practice, a systematic review may start with a broad scope, and be divided 
up into narrower reviews as evidence accumulates and the originally review 
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becomes unwieldy.  This investigation took this approach, as the original 
question hoped to achieve a broad point of comparison among all local 
anesthetic solution.  As evidence was gathered and a high level of heterogeneity 
identified, a more narrow focus was adopted for practical and logistical reasons. 
In this investigation, the original research question was of a broad scope.  
The Population under consideration being all patients receiving dental treatments 
in a clinical setting.  The Intervention included all types of local anesthetic 
solutions approved for dental therapeutic use.  The Outcome was the 
achievement of profound anesthesia of the dental pulp.  As the question was 
narrowed, the addition of the Comparison component of the PICO question 
specifically aimed to compare the anesthetic success associated with lidocaine 
versus articaine (Table 3.1).  Data identified from the focus of this narrow based 



































Final Question Format 
The PICO framework was used to formulate the following questions for a 
systematic review of the existing literature: 
• BROAD SCOPE:  In patients receiving dental treatments, which local 
anesthetic solution provides the highest percentage of successful 
anesthesia for various clinical situations? 
• NARROW SCOPE:  In adult patients receiving operative or endodontic 
treatments, does using an articaine solution for local anesthesia 
compared to lidocaine provide superior pulpal anesthetic efficacy? 
 
C#+'"'"D)="(EF$'A"G*H(EF$'A")85'%#5', 
Studies were considered relevant to this analysis if they included specific 
defined characteristics. Initially, the broad scope question was employed to focus 
the literature searching process.  The following characteristics were considered 
during the study selection process: 
Population -  Included trials were limited to human, adult subjects.  An initial 
review of the methodologies of trials involving pediatric poplulations revealed a 
wide variety of outcome measurement devices that made analysis impractical 
(Table 3.2).  Comparison of these outcomes to those of trials utilizing the EPT or 
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Timeline -  To keep the investigation relevant to contemporary solutions 
and administration techniques trials published before1970 were excluded.  This 
allowed for a near 40-year range of data for a comprehensive summary of the 
topic. 
Language -  The initial group of included studies was limited to those 
published in the English language.  Throughout the study identification and 
selection process, it was identified that publications in English directly comparing 
articaine and lidocaine were sparse, likely because the delay in FDA approval of 
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articaine for use within the U.S.  Thus, for the meta-analysis portion, the 
language limitation was removed, and publications in all languages were 
included for inclusion. 
Study Characteristics -  Included studies within this review were limited to 
randomized controlled trials (RCTs).  Quality of randomization and 
appropriateness of experimental controls were discussed among the research 
team, and studies were defined as RCTs when consensus was reached. 
Assessments of Anesthetic Success -  Publications were included in they 
defined anesthetic success as “none” or “mild” pain measured using a standard 
or modified VAS during clinical instrumentation.  If there was no instrumentation, 
success was measured by no response by the tooth to maximal stimulation with 






The Medical Subject Heading (MeSH) database, the National Library of 
Medicine’s controlled vocabulary indexing system, was used to search terms that 
would be related to this study.  The principle areas of interest were the location of 
dental articles, those concerned with the discipline of endodontics, and 
publications detailing the anesthetic solutions of interest.  An example of MeSh 
terms that were utilized in this investigation and the number of identified 




To identify publications that included the variety of local anesthetic 
solutions commonly used in clinical dentistry, all potential names and labels of 
each solution was recognized (Appendix III).   
Multiple electronic databases were used to locate and recover 
publications relevant to this investigation (Appendix IV).  Using PubMed, the 
National Library of Medicine’s text-based search and retrieval system for 
biomedical literature, a search through June 2009 was executed.  A similar 
search strategy was used for Embase (Excerpta Medica Database, Elsevier).  
To validate the focus of each search strategy, five known articles of 
interest were confirmed to be contained within the results of each database 




Both the MEDLINE and Embase search strategies contained all five seminal 
articles, and their focus was deemed appropriate for this investigation. 
 
Hand-Searching!
In addition to publications located by this electronic search strategy 
attempts to enrich the available references were made.  Hand searches were 
made by reviewing the reference lists of relevant articles and clinical trials and 
the tables of content of the journals containing most of the included studies for 
the last two years. 
A total of 32 individual journals produced the 119 articles that were 
selected for full-text appraisal.  It was calculated that 80% of these articles were 










The tables of content of these seven journals was reviewed for a period of two 
years.  No additional trials were located that could potentially contribute data to 
this review. 
 Recommendations of experts in the field of local anesthesia in dentistry 
were considered.  Articles were suggested by Prof. A. H. Jeske DMD, 
Department of Restorative Dentistry and Biomaterials, University of Texas Dental 
Branch–Houston.  Dr. Jeske is noted as a prolific writer on the topic of pain 
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control in dentistry, including local anesthesia, and has authored or co-authored 
a total of sixty articles.  Additionally, studies for consideration were offered in 
conversations with Professor A. Reader DDS MS, director of the Ohio State 
University’s Advanced Endodontics Program, who has published more than fifty 
trials on the topic of local anesthesia in dentistry throughout the past decade.  All 
expert recommendations were included within the results of the original database 




Electronic searching produced 734 publications when combining the main 
areas of interest.  When this set was limited to articles published in English, and 
those involving human subjects only, 422 articles remained to review at the title-
only level (Figure 3.2).  Lists of these publication titles were reviewed without 
knowledge of author or journal of origin in order to remove any known or 
subconscious bias of the reviewer.  Titles that were obviously of non-dental origin 
were removed, and any questionable titles were included at this stage for further 
review. Abstracts were then gathered and reviewed and any publications that 
were inappropriate for this investigation were excluded.  Again, if the abstract did 
not contain enough detail to determine the quality or methods of a specific trial, it 
was included for more detailed review.  Following the exclusions made at the 
abstract level, a total of 119 publications remained as potential articles of 
interest.  
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Full text copies of the 119 articles that were identified by title and abstract 
search were obtained for critical appraisal.  A pilot study was conducted to 
calibrate the two independent researchers regarding their decisions of inclusion 
or exclusion.  For a sample of 5 articles, two observers independently appraised 
each publication, and a third reviewer served to arbitrate the reports.  Consensus 
was reached, and the independent reviewers were considered calibrated. 
This process was repeated with three additional random sets of five 
articles each (N=15).  The first author reviewed each article, noting the specific 
methods of each trial and whether each trial met the defined inclusion criteria and 
this process was also undertaken by the independent reviewer.  All decisions 
were reviewed by a third member of the review team and compared for reliability.  
Any disagreements were then resolved by means of discussion and consensus 
between the three reviewers was reached.  After this process of calibration, the 
first reader continued the review of the remaining articles.  Before finalizing the 
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exclusion list, the review team discussed each excluded study and resolved any 
remaining discrepancies.  The process resulted in the final list of excluded 
studies (Table 3.3). 
The first group of exclusions were ten studies that included only children 
and adolescents as their subjects (Table 3.2).  An additional ten trials were 
excluded because their assessment of pulpal anesthesia was either completely 
absent, unacceptable, or poorly described.  A total of eleven articles could be 
eliminated because they were case series reports of various techniques or 
solutions without   control groups.  Nine of the trials were excluded because 
subjects were not randomly allocated into groups.  Two publications were 
retrospective in nature and one was an observational study that did not properly 
assess pulpal anesthesia.  In addition to these groups of exclusions there were 
other reasons for exclusion.  One article described an intra-osseous method of 
anesthesia and did not include any clinical data.  One well-designed trial 
evaluated the efficacy of electronically induced dental anesthesia but did not 
include any local anesthetic solutions and was thus excluded.  One trial was 
excluded on the basis that diagnosis, administration of the anesthetic and 
evaluation was performed by a single, un-blinded examiner.  Two trials were 
excluded as the trials were halted because of complications associated with the 
experimental groups.  See Table 3.3 for the detailed list of excluded trials and 
the corresponding reasons for exclusion. 
Before finalizing the list of excluded publications, the review team 
discussed each excluded study and resolved any remaining uncertainties 
regarding the articles status.  After arriving at consensus among the team of 
investigators, a total of 71 original articles were deemed to have met the criteria 




Attention was paid to the quality of methodology of included trials, and 
indicators of quality were recorded on the abstraction form.  These included 
proper randomized allocation of subjects to their respective study groups as well 
as blinding of subjects and evaluators.  Clinical trials were considered 
randomized if random sequences were generated by random numbers or tables, 
a tossed coin, or any other random sequence generation. If just the terms 
randomized or randomly allocated were used with no detailed information on the 
exact method, the trial was deemed ‘unclear’ as regards to the randomization, 
and clarification was sought by attempted contact from the original authors.  
Allocation was considered concealed if measures of allocation concealment were 
described, such as the use of opaque, sealed and sequentially numbered 
envelopes, or if anesthetic cartridges were indistinguishable, and sequentially 
numbered.  The examiners of each trial were deemed to be properly blinded if 
the outcome assessor could not know to which group the participants had been 
randomized.  Reporting of adverse events was recorded as being present if 
reported, or noted as ‘not mentioned’ if no description of side effects was 
included in the results.  The “Intent to treat” was considered adequate because 
treatment effects were observed and evaluated on the same day of intervention.  
For the trials that employed a cross-over design, it was noted that no losses 
occurred, and outcome data was available for all randomized subjects.  Thus, all 
participants were included in these trials, and should be considered as an “intent 
to treat” analysis.   Analysis appropriateness was assessed (Appendix II), and 
funding sources for included trials were reviewed to evaluate the existence 
funding bias.   
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Data Abstraction Process 
An initial data abstraction form was designed and served as a unified 
framework to record the research design parameters including information 
pertaining to the quality of the study.  This form allotted space for both 
categorical and quantitative entries, depending on the particular item of interest.  
(Appedndix VI) 
A pilot study was conducted to observe agreement between two 
independent researchers and to test the utility of the abstraction form.  For five 
randomly selected articles, two observers independently abstracted data using 
the form, and a third party of the research team reviewed and arbitrated the 
reports.  Minor adjustments were made to the data abstraction form as deemed 
necessary, and any disagreements were resolved. 
Following the pilot and confirmation of complete observer agreement, the 
full-text version of each study was reviewed, and data was extracted using the 
revised data abstraction form.  Again, a third party member served to arbitrate 
any disagreement among the abstracted data.  Once consensus was achieved, 
the data were prepared for analysis. 
The data recorded in the abstraction form included both information 
regarding the quality of the included trials, as well as their outcomes.  
Determination of proper randomization and blinding, as previously described, 
was noted on the form.  Details of the study population included the sample size, 
mean age of participants, as well as age range.  The goal of anesthesia was 
identified, being either an evaluation of an anesthetic solution on the pulpal 
innervation of teeth tested, or of soft-tissue being instrumented.  The goal of 
anesthesia was labeled as ‘pulpal’ or ‘surgical’, respectively.  Site of administered 
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anesthesia was noted as buccal or lingual if an infiltration was employed.  If block 
anesthesia was being investigated, the specific technique used was noted, as 
were other supplemental techniques.  Anesthesia of the maxilla or mandible was 
recorded.  The specific intervention was qualitatively (type of anesthetic solution) 
and quantitatively (mg dose of administered anesthetic) described.  Dichotomous 
data described the outcomes as either “anesthetic success” or “anesthetic 
failure” (Appendix VII –Glossary of Terms). 
 
Meta-Analysis 
Because the evidence comparing lidocaine to articaine was sparse, the 
language restriction was modified prior to final data analysis.  Because articaine 
has been in use in both Europe and Canada for several decades, the English-
language restriction was removed in an attempt to find meaningful data that may 
have been published in an alternative language.  This additional searching 
revealed six potential publications for inclusion into the meta-analysis, and the 
full-text versions were obtained, translated, and appraised.  Four articles were 
originally published in German language (Winther 1972, Khoury et al. 1991, 
Ruprecht & Knoll-Köhler 1991, Szabó et al. 1988).  The publication by Khoury et 
al. was excluded because its methods did not meet the inclusion criteria for 
assessment of pulpal anesthesia.  The publication by Szabo et al. was also 
excluded, as it included data on duration and diffusion of anesthesia, but no 
designation of anesthetic success.  One article was located from a Croatian-
language publication (Amsel & Katanec 1986), but was excluded because there 
was no randomization of subjects in the trial.  And finally, one Russian 
publication (Anisimova et al. 1997) was excluded on the basis that there was an 
absence of randomization and the evaluator was unblinded to the interventions.  
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For the meta-analysis portion, two independent evaluators and a third-
party arbitrator served as the review team, and reached complete agreement for 
the abstracted data.  Data for meta-analytic comparisons were obtained from the 
arbitrated abstracted data. 
Statistical analysis of the extracted outcomes data was conducted using 
the RevMan software (Review Manager Version 5.0, Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2008).  Mantel–Haenszel odds 
ratios were calculated to describe the overall estimated treatment effects of 
licocaine versus articaine across the multiple quantitative scientific studies.  This 
was done for an overall broad comparison of all direct comparisons of lidocaine 
and articaine, and then repeated to select data for the techniques of infiltration 
and block anesthesia separately.  Forest plots from this data were constructed to 
illustrate the estimated treatment effects graphically.  The Q statistic value was 
calculated according to the method of Cochrane to test for heterogeneity among 
the reported results of the studies.  A funnel plot of the included trials was 
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The 72 studies that were identified as randomized clinical trials (RCTs)  
Variations in methodology and quality of design were present and are presented 
in Figures 4.1 – 4.4. 
 
Timeline 
 The earliest publication that met the inclusion criteria of this review was 
published in 1972 (Winther & Nathalang 1972). This was also the first clinical trial 
that reviewed the efficacy of articaine in clinical dentistry.  Figure 4.1 depicts the 
number of randomized, controlled trials per 5-year period.  Only one trial was 
published in each of the initial two 5-year periods, and 33 in the final 5-year 
period.  This trend is encouraging, as more high-level evidence is published, 
conclusions of this systematic review will be strengthened. 






 The United States dominated the count of investigations, in terms of 
country of origin of each included trial, with 45 of the 72 RCTs.  Brazil, the United 
Kingdom, Canada, and Denmark each contributed multiple studies that were 
included into this investigation.  And finally, a single included study was found 
from India (Srinivasan et al. 2009), Finland (Vähätalo et al. 1993), Egypt 
(Elsharrawy & Elbaghdady 2007), Korea (Jung et al. 2008), and Iran (Modaresi et 
al. 2006).  This wide geographic distribution represents a variety of populations 
(Figure 4.2). 
 
Figure 4.2  Geographical Summary of Randomized, Controlled Trials 
 
Pulpal Status 
 As defined by our inclusion criteria, trials must have evaluated the 
condition of the dental pulp for each subject prior to anesthetic administration.  
Within this review, the majority of RCTs which were included evaluated the 
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anesthetic efficacy of the various solutions available for dentistry on teeth which 
contained healthy and/or uninflamed pulps.  Twelve of the included RCTs 
investigated the effects of local anesthetic solutions on vital teeth that had been 
diagnosed as having irreversible pulpitis.  The American Association of 
Endodontists includes explicit definitions of the various conditions of pulpal 
health, including those states that were evaluated within this review: 
o Normal pulp – a clinical diagnostic category in which the pulp is 
symptom free and normally responsive to vitality testing 
o Irreversible pulpitis – a clinical diagnosis based on subjective and 
objective findings indicating that the vital inflamed pulp is 
incapable of healing 
 The distribution of trials included in this investigation regarding the pre-
operative pulpal status is exhibited in Figure 4.3. 
 
 






 Two main approaches for determining anesthetic efficacy were identified, 
and these methods had varying definitions of successful anesthesia.  The most 
common method was the EPT- based methodology. The EPT is an instrument 
that uses gradations of electric current to excite a response from the nervous 
tissue within the pulp.  Among the trials that employed this methodology, a 
variety of specific protocols was identified.  All of the studies recorded a baseline 
EPT value prior to the administration of the experimental anesthetic solution.  
Following the anesthetic administration, the EPT was used in cycles ranging from 
every 20 seconds, to longer periods of several minutes, for a predetermined 
duration.  Timelines to completion of the trials also varied, including 30 or 60 
minutes post-injection, or until the return of baseline EPT values, regardless of 
time.  The anesthetic success rate utilizing this method was often defined as the 
percentage of subjects who achieved two consecutive maximal stimulations 
without sensation within 15 minutes of anesthesia administration, and 
continuously sustained this lack of responsiveness for some period.   
 The second approach had the patient give a pain rating using a pain-
scale instrument during various clinical treatments that were considered to only 
impact pulpal tissues.  The most common pain scale with this methodology was 
the visual analogue scale (VAS) but other pain-scales were also used.  These 
psychometric response scales have been used as a measurement instrument for 
subjective characteristics such as dental pain and have been successfully used 
primarily in dentistry for patients who are symptomatic.  This type of 
measurements requires some type of experimental dental treatment that would 
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be associated with pain if profound anesthesia had not been achieved.  The 
inclusion criteria of this systematic review aimed to select trials that evaluated 
pulpal anesthesia only and not those that could have based success or failure on 
the innervation of periodontal or osseous origins.  A variety of VAS instruments 
were seen.  For example, Srinivasan  quantitatively measured the pain of 
endodontic access on anesthetized teeth using a standard VAS ranging from 0 to 
10cm, categorizing successful anesthesia as a response value of “0” or “1” 
(Srinivasan et al. 2009).  Conversely, Mikesell et al. used a modified Heft Parker 
VAS ranging from 0 to 170mm, defining anesthetic success as a patient reporting 
a pain level <54mm, which includes the categories of mild, faint, and weak pain 
(Mikesell et al. 2005, Heft & Parker 1984).  All varieties of VAS scales reasoned 
that reported pain related to anesthetic failure, and lack of reported intra-
operative pain equated to anesthetic success. 
 Various other measurements of experimental outcome were also 
identified among the included publications.  One trial utilized both EPT and VAS-
based methods to determine successful anesthesia after local anesthetic 
administration (Tortamano et al. 2009).  Other validated measurement scales 
were employed, including a 5-point scale to rate pain associated with invasive 
procedures (Elsharrawy & Elbaghdady 2007), and a similar pain-rating scale that 
evaluated tooth sensitivity levels after local anesthesia administration (Modaresi 
et al. 2006). One trial strictly defined anesthetic success as the patient rating 
“absence of pain” during a procedural-based evaluation (VanGheluwe & Walton 
1997).  And finally, the first two published trials within the group of included 
studies employed the AB Bofors Pulp Tester, which is an earlier version of the 
EPT (Petersen et al. 1977, Winther & Nathalang 1972).   Figure 4.4 depicts the 
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Figure 4.4 – Response Measuring Instruments Used in Included Trials 
 
Review of Methodologies 
 Dentists employ multiple techniques to deliver local anesthetic solutions 
to desired anatomical locations to inhibit the conduction process of peripheral 
nerves.  Researches have investigated these varying techniques, and their 
publications are the basis for this systematic review.  The overall variety of 
methods of local anesthesia delivery is mirrored in the varying methodologies of 
the included publications (Figure 4.5). 
 The two most common methods for delivering local anesthetic solutions in 
clinical dentistry are infiltration and block anesthesia (Malamed 2004).  These 
two means are considered within this review to be the primary routes of 
anesthesia delivery, and included trials were categorized into respective groups 
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based on their techniques employed.  A total of 14 RCTs included in this review 
investigated the efficacy of local anesthetic solutions when given via local 
infiltration.  Block anesthesia was evaluated by a total of 21 trials.  An additional 
14 publications studied the combination of techniques, and were placed into a 
designated category separate to those that investigated infiltration or block 
anesthesia solely. 
 Supplemental techniques were the focus of several RCTs.  Anesthetic 
delivery by direct intra-ligamentary injection or by the creation of a channel to the 
osseous tissues by using a perforating instrument, such as the Stabident" or X-
tip" have been investigated.  The total number of such publications that met the 
inclusion criteria were eight and six, respectively.  One controlled trial looked at 
the efficacy of intra-pulpal delivery of anesthetic solutions by injecting directly 
within an endodontically accessed pulp (VanGheluwe & Walton 1997). 
 Still other investigations were identified that evaluated other aspects that 
could affect the efficacy of local anesthesia in clinical dentistry.  These topics 
ranged from the impact of the female menstrual cycle (Tófoli et al. 2007), the 
influence of previous alcohol addiction (Fiset et al. 1997), or the degree of needle 
deflection when administering the anesthetic solution (Steinkruger et al. 2006).  
Additions of a variety of chemical compounds to local anesthetic solutions were 
investigated, including hyaluronidase (an enzyme which increases tissue 
permeability) (Tempestini Horliana et al. 2008, Ridenour et al. 2001) and fentanyl 
(a potent narcotic analgesic) (Elsharrawy & Elbaghdady 2007).  
Pre-operative administration of oral systemic medications prior to local 
anesthesia delivery has also been inspected, including sedative hypnotics, and 
oral analgesics (Ianiro et al. 2007, Modaresi et al. 2006).  
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 The aim of the first analytic approach compared the estimated effects of 
articaine and lidocaine.  The combination of studies and examination of their 
entire data supplied greater power to the conclusions of this analysis.  Within the 
group of RCTs meeting inclusion criteria for this review, those publications 
directly comparing experimental administrations of articaine and lidocaine were 
identified.   This sub-group originally totaled thirteen trials.  As previously 
described, these results were further enriched with the data from two non-English 
language trials that met our inclusion criteria.  The outcomes data of these fifteen 
trials was the basis of this meta-analysis. 
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Tests for heterogeneity indicated strong evidence of heterogeneity among 
the estimated treatment effects of these fifteen studies.  For all studies combined, 
the chi-squared value associated with the test of heterogeneity was 24.12 with 12 
degrees of freedom, and a p-value < 0.00001 was obtained. The Cochrane 
collaboration recommends using a p-value of less than 0.10, rather than the 
conventional cutpoint of p=0.05. A chi-squared value larger than the number of 
degrees of freedom, is also evidence of heterogeneity.  On this basis, a random 
effects model of statistical analysis was employed rather than fixed effects 
models used when there is no evidence of heterogeneity. 
 Estimates of treatment differences between the two anesthetic solutions 
are shown in Figure 4.6.  This comparison depicts a broad scope of comparison 
between these two solutions, irrespective of technique or site of administration.  
The overall odds ratio of articaine producing successful anesthesia compared to 
lidocaine is estimated at 2.3, and the results are statistically significant (the 95-
percent confidence interval ranges between 1.62 and 3.26).  These odds ratios 
are base on the pooled data of the fifteen selected studies, and is supported by 




 The outcomes data were further stratified into separate categories based 
on whether the local anesthetic solutions were administered via a block or an 
infiltration.  These analyses also identified a trend of superiority of articaine over 
that of lidocaine in terms of achieving anesthetic success, although these results 
were not statistically significant.  When infiltration anesthesia only was 
considered, the weighted odds ratio was 3.54 in favor of articaine (95 percent 
confidence interval ranged from 2.57-4.87, respectively).  For clinical trials 
directly comparing articaine and lidocaine when administered via a block 
technique, articaine was modestly favored with an odds ratio of 1.38 (95 percent 
confidence interval ranged from 0.79 to 2.40).  The relative strength of the 
treatment effects of lidocaine when administered by infiltration are illustrated in 
Figure 4.7, and when administered via block technique in Figure 4.8. 
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A funnel plot depicting the estimated treatment effect (odds ratio) on the 
horizontal axis and ‘study size’ (in this case standard error) on the vertical axis is 
seen in Figure 4.9.  This graph is designed to check the existence of publication 
bias in a meta-analysis. The graph depicts 13 data points representing the 
included studies.  Data points are not present for the data from Oliviera et al. 
2004 or Costa et al. 2005 because within those trials all administrations of 
lidocaine and articaine resulted in anesthetic success, and thus no odds ratios 
were estimated. The fact that an inverse funnel pattern is not present in this 
funnel plot suggests that possible publication bias existed in this group. 
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Publication bias suggests that smaller studies showing significant results may be 









Reduction of Bias 
The Cochrane Collaboration advises that the determination and reduction 
of bias be the major approach in the assessment of quality of trials within a 
systematic review.  Within this review, quality measures were designed to reduce 
bias.  Strategies were conducted to use modern search engines to thoroughly 
seek for all relevant publications.  It remains possible that publication bias may 
affect this review as unfavorable and negative results tend to go unpublished.   
Performance bias was also assumed to be eliminated by confirming the 
masking and calibration of subjects, operators, and evaluators among the 
included studies.  The intention to treat analysis revealed no losses within the 
study designs of included trials, and has been described as being more suitable 
for pragmatic trials of effectiveness rather than for explanatory investigations of 
efficacy (Hollis & Campbell 1999).  No conflicts of interest between authors and 
their funding sources were noted, indicating the absence of funding bias. 
 
Evaluation of Successful Anesthesia 
 Traditional methods to confirm successful pulpal anesthesia in clinical 
dentistry may involve questioning the patient, stimulating adjacent soft-tissue, or 
simply commencing with treatment.  A number of publications have pointed out 
that these approaches are less than ideal, and may not be effective for 
determining pulpal anesthesia.  A clinical trial by Chaney et al (Chaney et al. 
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1991) demonstrated that although all of the subjects reported a subjective 
“feeling of numbness”, pulpal anesthetic success was as low as 2%.  They 
concluded that lip numbness and negative mucosal responses did not always 
indicate onset or guarantee successful pulpal anesthesia.  Similar conclusions 
have accompanied a number of other clinical trials regarding dental anesthesia 
(Vreeland et al. 1989,McLean et al. 1993, Hinkley et al. 1991). The application of 
refrigerant spray has also been used to determine pulpal responsiveness (Jones 
et al. 2002). 
 The electronic pulp tester (EPT) determines anesthetic success in a more 
accurate and objective manner.  Clinically, application of the EPT can be used to 
test the tooth under treatment for pulpal anesthesia prior to beginning a clinical 
procedure (Dreven et al. 1987, Certosimo & Archer 1996).  
 When using stimulus of dental pulp in an effort to determine the sensitivity 
of the dental pulp, various explicit definitions of success have been employed.  A 
common way to define success when using EPT is the percentage of 
experimental subjects who achieve two consecutive 80 reading on the EPT 
within 15 minutes of local anesthetic administration, and sustain this lack of 
responsiveness for some predefined duration (usually 60 minutes) (Vreeland et 
al. 1989, McLean et al. 1993,Chaney et al. 1991,Hinkley et al. 1991, Hannan et 
al. 1999, Fernandez et al. 2005, Nusstein et al. 2002).  Alternatively, anesthetic 
failure has been defined as the percentage of subjects who never achieved two 
consecutive maximum readings at any time during a predefined duration. 
 The electric pulp tester is technique sensitive (Cooley & Barkmeier 1977, 
Ehrmann & Millard 1973).  The requirements to achieve a valid EPT outcome 
are: adequate stimulus, appropriate application method, and careful 
interpretation of results.  Tests require tooth isolation and conducting media.  
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Explaining to patients that an electric stimulus will be applied to their tooth may 
be frightening, and the stimulus may sometimes be painful.  Additional difficulties 
with this method are encountered when teeth have extensive restorations, or are 
wearing orthodontic bands.  In these cases, the response may be caused by 
conduction of the current to the gingival or periodontal tissues and adjacent teeth 
through these conductive materials (Fulling & Andreasen 1976).  Nevertheless, 
the EPT has been used in research applications in analgesia for many years.  
The first investigation to utilize the EPT for evaluating the effectiveness of local 
anesthetics occurred in 1947 (Bjorn 1947), and has continued to be used as an 
indicator of the effectiveness of local anesthesia in clinical trials to this day.  This 
has been reflected among the included trials of this investigation. 
 
Reporting of Clinical Trials: 
This meta-analysis combined data from the publications that directly 
compared the two most commonly used local anesthetic solutions in the United 
States: lidocaine hydrochloride and articaine hydrochloride.  The individual 
publications had a variety of outcomes and conclusions; however, the meta-
analysis of their combined data revealed that a significant difference exists 
between these two anesthetic agents.  These results favor an advantage of using 
the articaine hydrochloride solution for producing anesthetic success.  Even 
within the subset of studies that were identified for the meta-analysis, numerous 
variations in methodologies were present.  Sources of heterogeneity included 
specific study designs, study populations, specific teeth that were tested, 
injection type, and even definition of outcome.  Additionally, complete 
standardization in reporting among the included trials was not present, leading to 
potentially inaccurate or incomplete reporting.  The lack of standardized research 
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protocols has been named as a significant limitation in a number of other meta-
analyses on dental topics (Keenan et al. 2005, Peng et al. 2007). 
 Because of the problems arising from inadequate reporting of 
randomized controlled trials, the CONSORT statement was developed (Altman 
1996).  Developed in 1993 by a group of medical journal editors, methodologists, 
and other researchers, the CONSORT statement is an evidence-based, 
minimum set of recommendations for reporting randomized trials. It offers a 
standard way for authors to prepare reports of trial findings, facilitating their 
complete and transparent reporting, reducing the influence of bias on their 
results, and aiding their critical appraisal and interpretation (Schulz et al. 2010).  
A recent systematic review determined that the utilization of the CONSORT 
checklist does improve the reporting of randomized controlled trials (Plint et al. 
2006).  This report suggested that with endorsement by more journals, and 
greater editorial efforts to ensure that authors comply, the CONSORT statement 
could begin to yield the full benefits for which it was intended.  It is encouraging 
that as time progressed, a greater proportion of the trials within this systematic 
review, and specifically those trials contributing to the meta-analysis, adhered to 
CONSORT in their reporting.   
 As stated, the fifteen studies that were summarized in the meta-analysis 
were inconsistent in methodology.  This heterogeneity required critical appraisal 
to interpret the individual validity of each study, and whether it met the inclusion 
criteria standards that were specifically set to regulate the quality of studies 
included for the comparison.   
 The meta-analysis included more subjects that any single 
component study comparing these two local anesthetic solutions. Sackett has 
described the systematic review of randomized controlled trials to be the “gold 
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standard” for judging the effects of a treatment or intervention, stating that it is 
“so much more likely to inform us, and so much less likely to mislead us” (Sackett 
et al. 1996).   In fact, the Oxford Centre for Evidence-Based Medicine touts the 
systematic review of randomized controlled trials as the highest level of evidence 
from which to base treatment decisions, recognizing that not all evidence is made 
accessible.  Inherent to the systematic review process are efforts to reduce 
publication bias and retrieval bias.  
Overall, the results of the meta-analysis were based on the inclusion of 
both male and female subjects between the ages of 18 to 60 years.  Among the 
studies that reported the mean age of their subjects, all described a mean age of 
younger than 30 years.  Also, the majority of subjects had reported “good” 
systemic health.  Included studies were limited to rather young populations, most 
likely because many of these trials recruited students as their subjects.  
Incomplete reporting among the included trials regarding the age and gender of 
their study populations did not allow for further analysis of the influence of these 
variables on the likelihood of anesthetic success. 
The meta-analysis compared volumes of local anesthetic solutions that 
were considered to be clinically reasonable.  Because of the difference in 
concentration between articaine hydrochloride and lidocaine hydrochloride 
preparations available on the market, a standard volume does not equate to a 
standard milligram dose.  One milliliter of anesthetic solution is equal to a 40 and 
20 milligram dose of articaine hydrochloride and lidocaine hydrochloride, 
respectively.  These differences may decrease the validity of comparisons of 
equal volume.  However, none of the included trials directly compared equivalent 
concentrations of articaine hydrochloride and lidocaine hydrochloride.  This meta-
analysis reflects the comparison of these two local anesthetic solutions as they 
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are commonly evaluated in the literature.   This means that equivalent volumes 
are compared, but not equivalent milligram doses.  It is beyond the scope of this 
investigation to comment on the influence of concentration differences on the 
respective success rates of articaine hydrochloride and lidocaine hydrochloride.  
Future research designed to investigate the influence of this dose effect is 
needed for clarification of this difference. 
The type of injection type was also a source of heterogeneity among the 
included studies.  All types and techniques of local anesthetic administration 
were considered for the overall comparison of the meta-analysis, resulting in a 
broad point of comparison.  When injection types were further stratified, the 
evidence more strongly supported a superiority of articaine over lidocaine with 
infiltration anesthesia, and weak evidence for such differences for block 
anesthesia.  The difference between success rates between articaine and 
lidocaine were statistically significant when the method of administration was an 
infiltration, as opposed to no statistically significant difference between the two 
when a nerve block was given. 
The strong evidence of superiority of articaine over lidocaine in 
administrations of infiltration anesthesia should be an evidence-based guide for 
clinicians.  However, clinicians cannot expect an improved success rate in 
achieving pulpal anesthesia when substituting articaine for lidocaine when the 
route of administration is a local block technique.  More data is needed to 
determine if an infiltration of articaine may enhance or even replace the IAN 
block.  Corbett et al reported that the efficacy of articaine when administered by 
infiltration was not statistically different than delivering lidocaine via an IAN block 
for anesthetic success in mandibular 1st molars (Corbett et al. 2008).  
Additionally, Jung et al found that the success rates of a standard volume of 
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articaine was not influenced by the administration route, be it buccal infiltration or 
IAN block (Jung et al. 2008).   
The trials that provided the basis for the meta-analysis also investigated a 
variety of teeth.  The various types of teeth studied included incisors, canines, 
premolars, and molars.  Again, the compilation of all of the data, regardless of 
selected tooth, was used for the meta-analysis.  If specific tooth type had been 
compared individually, either the number of studies to compare would have been 
greatly reduced, or comparisons would have been altogether impossible.  The 
combination of numerous tooth types in this study offers a broad point of 
comparison and represents the wide variety of teeth that are treated in dentistry.   
Also, the meta-analysis included all pulpal diagnoses for comparisons, 
assuming that the pre-stated inclusion criteria of a pre-operative assessment of 
pulpal health status was present for each of the included trials.  For the meta-
analysis, the majority compared the efficacy of the two local anesthetic solutions 
in teeth with healthy pulps.  Four of the included trials made investigations 
among patients who had been diagnosed with having irreversible pulpitis.  This 
trend of having a majority of studies containing healthy, asymptomatic teeth was 
echoed in the overall systematic review of all local anesthetic solutions in clinical 
dentistry.  Regarding this meta-analysis, additional well-designed and sufficiently 
powered trials will be needed to highlight differences in the odds ratios of healthy 
or diseased teeth of obtaining anesthetic success when using articaine 
hydrochloride versus lidocaine hydrochloride.  Because both pre-operative 
conditions were considered for this meta-analysis, the results reflect a variety of 
pulpal conditions. 
It was an aim of this review to determine differences in time of onset and 
duration of anesthesia between articaine hydrochloride and lidocaine 
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hydrochloride.  However, because individual patient data was not available, 
meaningful statistical comparisons of these outcomes were not possible.  
Because the literature was not standardized and had variations in reporting, the 
influence of gender, age, injection type, tooth type, and pulpal status was not 
completed.  Still, the main comparison of the dichotomous outcome of “success” 
versus “failure” was possible, and is a meaningful summary of high-level 
evidence for clinicians.   
It was also noted that there does exist a difference in cost between the 
two local anesthetic solutions.  Using the product catalog of Henry-Schein, a 
worldwide distributor of medical, dental, and veterinary products, a package of 
fifty carpules of articaine hydrochloride can be purchased for $38.99.  When 
compared to purchasing the same quantity of lidocaine hydrochloride for $29.99, 
this results in a cost ratio articaine hydrochloride costing 1.3 times greater than 
lidocaine hydrochloride.  This increased cost seems warranted, considering the 
estimation of this meta-analysis that articaine hydrochloride is 2.3 times more 
likely to produce anesthetic success than is lidocaine hydrochloride.  The 
difference in cost may be considered even more negligible when considering 
infiltration anesthesia, where articaine was estimated to be 3.5 times more likely 
to provide successful anesthesia. 
The likelihood of complications associated with these two local anesthetic 
solutions was outside the scope of this meta-analysis.  However, within the 
subset of data which was the basis for this meta-analysis, it should be noted that 
no reports of paresthesia were associated with the 1175 administrations of 
articaine hydrochloride, or the 1120 administrations of lidocaine hydrochloride.  
Reported adverse events did include minor bruising or swelling in the area of the 
injection, although not all of the included trials stated the presence or absence of 
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complications.  Data in the dental literature is ambiguous regarding the 
comparative safety of these two local anesthetic solutions.  One retrospective 
study that reviewed over twenty years of data in Canada reported 143 cases of 
paresthesia following local anesthetic administration, with 49 percent being 
associated with articaine hydrochloride, and only 5 percent from lidocaine 
hydrochloride (Haas & Lennon 1995).  This publication concluded that articaine 
hydrochloride was significantly associated with paresthesia and that lidocaine 
hydrochloride was not.  However, this data was based on voluntary reporting 
from dentists, often lacking pertinent details including the size and caliber of the 
needle used, the injection techniques used, or the total duration of paresthesia.  
Additionally, the type of anesthetic used was not identified in over 30 percent of 
these reports, which could have shifted the conclusions of this analysis 
significantly (Haas & Lennon 1995).  A more recent article regarding reported 
cases of paresthesia evaluated by the Oral and Maxillofacial Surgery Department 
of the University of California at San Francisco stated that 35 percent of the 
paresthesia involved the use of lidocaine hydrochloride, versus 30 percent being 
associated with articaine hydrochloride (Pogrel 2007).  It was concluded that 
paresthesias were not significantly more likely when articaine hydrochloride was 
administered.  The author stated that a clinician should be knowledgeable about 











Well-designed and properly executed randomized controlled trials provide 
the best evidence on the efficacy of health care interventions, while trials with 
inadequate methodological approaches may be associated with exaggerated 
treatment effects.    
Further comparative trials investigating the difference in anesthetic 
success between articaine and lidocaine are warranted to strengthen the 
evidence that formed the basis for this review.  Specifically, comparisons 
between these two solutions among older populations, as well as equivalent 
doses are currently absent in the dental literature.  It is also suggested that a 
uniform pain scale be adopted to compare the efficacy of articaine and lidocaine 
in pediatric populations.  Standardization in reporting of clinical trials of dental 
anesthetics should be improved, especially among the parameters of duration 
and onset of anesthesia.  These comparisons would be of great interest to 
clinicians, but are not currently possible because of inconsistent or absent 
reporting of present clinical trials.  Such randomized controlled clinical trials could 
expand the existing evidence regarding the superiority of articaine over lidocaine 







When comparing the newer articaine solution to the “gold standard” of 
lidocaine, an emerging trend was identified from the review of contemporary 
research.  The results of these studies have often demonstrated a superior 
anesthetic efficacy for articaine, even though proper statistical analysis frequently 
reveals that such differences were not always statistically significant.  This meta-
analysis summarizes the unbiased direct comparison of articaine and lidocaine, 
and supports the argument that articaine does provide a higher rate of anesthetic 
success.  This evidence-based review is aimed to facilitate clinicians in making 
informed, judicious decisions when selecting a local anesthetic solution. 
Clinicians may expect a solution of articaine hydrochloride to provide a 
greater probability of anesthetic success than a solution of lidocaine 
hydrochloride, with the superiority of articaine being most significant when used 
during local infiltration anesthesia. Regarding the relative strength of treatment 
effects among the multiple quantitative studies, it can be stated that within a 95 
percent confidence interval the true odds ratio of articaine hydrochloride is 1.62 
to 3.26 times more likely to produce anesthetic success than lidocaine.  When 
considering infiltration data only, the present meta-analysis estimates that 
articaine is 3.54 times more likely to produces anesthetic success than a similar 
volume of lidocaine.  There is weak evidence that the use of articaine allows for a 
higher percentage of anesthetic success when administered via a IAN block, and 
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• Appendix I: 
Commercially Available Solutions for Local Anesthesia  
(Manufacturer Data) 
 































Citanest Plain 10-15 min 45-65 min 3-4 hrs 72 
Articaine HCl 4%  
w/ epi 1:100,000 
Septocaine,  
Zorcaine 
60-75 min Up to 120 
min 
3-5 hrs 68 
Articaine HCl 4% 
w/ epi 1:200,000 
Septocaine 60 -75min Up to 120 
min 
3-5 hrs 68 
Lidocaine HCl 
2% 






55-65 min 80-90 min 3-5 hrs 36 
Lidocaine HCl 
2% 






55-65 min 80-90 min 3-5 hrs 36 
Mepivicaine HCl 
2% 


















w/ epi 1:200,000 
Citanest Forte 35-45 min 50-70 min 3-6 hrs 72 
Long Duration Bupivacaine HCl 
0.5% 




Up to 7 
hrs 




*Abbreviations used:  epi = epinephrine,  levo = levo nordefrin
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APPENDIX II: 
Initial Review of Generated Studies’ Methodology and Reporting 
 
Author Outcome Measurements/Reporting Statistical Analysis 
Sherman 
2008 
Modified VAS (170mm)was used before treatment: 
0mm= no pain, 1-54mm = mild pain,  
55-113 = moderate pain, 114+ = severe pain. 
Pt’s contralateral canine used as a control. 
No response to endo ice on experimental tooth 15 min 
after injection indicated pulpal anesthesia. 
After access was completed, pts used same VAS to rate 
discomfort. 
X2 comparisons. 
Regression analysis of 
pulpitis pain before tx 
compared to pain after 
tx by using Spearman 




Investigator of anesthetic efficacy was blinded to the 
infiltration method.  Pulpal anesthesia was determined by 
using an EPT.  Tooth was tested 2x before injection, and 
then every 2 min after injection for 30 min. 
Successful anesthesia was no response to maximum 
stimulation on two or more consecutive measurements.  
Duration measured until more than 2 responses at less 
than maximum stimulation. 
Injection discomfort for each injection rated on a VAS 
(100mm) scale. 
Pearson X2, Fisher’s 
exact test, McNemar 
test, and Student’s T 







Used Articaine 4% with epinephrine 1:200,000 
Efficacy was scored as 0 when the anesthesia did not 
allow the treatment to be completed, 1 when the treatment 
was completed with no pain or sensitivity, 2 when the 
treatment was completed despite mild sensitivity, and 3 
when the assessment could not be performed. 
X2 test, P<.05 
Gregorio 
2008 
Crossover study, Articaine used for one 3rd molar 
removal, and then Bupivicaine used at least 1 mo later for 
the ipsilateral tooth (same surgeon). 
The parameters evaluated were: 
Total anesthetic volume used, onset (soft tissue), quality 
of anesthesia (based on 3 point scale), difficulty of 
surgery (based on 3 point scale), duration of the surgery 
(1st incision to last suture), duration of analgesia (time at 
end of surgery and the first ingestion of piroxicam for 
pain), duration of anesthesia on soft tissues, subjective 
pain evaluation on a VAS scale (100mm) 
Paired t test, ANOVA, 
followed by Tukey’s 












Before injections, the experimental tooth was tested 3x 
with the EPT for baseline.  Heft-Parker VAS (170mm) 
used to rate each phase of the injection.  No pain=0mm, 
mild= 0-54, moderate= 55-114, severe= 114+.   After 1 
min, EPT reading taken for the experimental tooth and 
the contralateral canine, continuing in 3 minute cycles for 
60 min.  Success = 2 consecutive non responses to 
maximum output. 
Group comparisons 
with exact McNemar 
test.  Between-group 
comparisons using 
ANOVA w/ a Tukey-
Kramer multiple 




Electronic Search Strategy development- 
Lidocaine 
 
PubChem Compound:  CID: 3676 
IUPAC: 2-diethylamino-N-(2,6dimethylphenyl)acetamide 
Entry Terms: 
    * 2-2EtN-2MePhAcN 
    * 2 2EtN 2MePhAcN 
    * Lignocaine 
    * 2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide 
    * Lidocaine Carbonate (2:1) 
    * Lidocaine Carbonate 
    * Carbonate, Lidocaine 
    * Lidocaine Hydrocarbonate 
    * Hydrocarbonate, Lidocaine 
    * Lidocaine Hydrochloride 
    * Hydrochloride, Lidocaine 
    * Lidocaine Monohydrochloride 
    * Monohydrochloride, Lidocaine 
    * Lidocaine Monoacetate 
    * Monoacetate, Lidocaine 
    * Xyloneural 
    * Lidocaine Sulfate (1:1) 
    * Octocaine 
    * Xylesthesin 
    * Xylocaine 
    * Xylocaine CO2 
    * Xylocitin 
    * Dalcaine 
    * Lidocaine Monohydrochloride, Monohydrate 
    * Monohydrate Lidocaine Monohydrochloride 
 
MeSH Categories: 
 Chemicals and Drugs Category 
  Organic Chemicals 
   Amides 
    Anilides 
     Acetanilides 




PubChem Compound;  CID: 4062 
IUPAC: N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide 
Entry Terms: 
    * Isocaine 
    * Novocol Brand of Mepivacaine Hydrochloride 
    * Isogaine 
    * Clarben Brand of Mepivacaine Hydrochloride 
    * Meaverin 
    * Aventis Brand of Mepivacaine Hydrochloride 
    * Mecain 
    * curasan Brand of Mepivacaine Hydrochloride 
    * Scandonest 
    * Dentsply Brand of Mepivacaine Hydrochloride 
    * Mepivacain-Injektopas 
    * Mepivacain Injektopas 
    * Pascoe Brand of Mepivacaine Hydrochloride 
    * Mepivacaina Braun 
    * Braun, Mepivacaina 
    * Braun Brand of Mepivicaine Hydrochloride 
    * Mepivacaine Hydrochloride 
    * Hydrochloride, Mepivacaine 
    * Mepivacaine Monohydrochloride 
    * Monohydrochloride, Mepivacaine 
    * Mepivastesin 
    * 3M Brand of Mepivacaine Hydrochloride 
    * Scandinibsa 
    * Inibsa Brand of Mepivacaine Hydrochloride 
    * Carbocaine 
    * Abbott Brand of Mepivacaine Hydrochloride 
    * AstraZeneca Brand of Mepivacaine Hydrochloride 
    * Scandicain 
    * Sanofi Brand of Mepivacaine Hydrochloride 
    * Carbocaïne 
    * Astra Brand of Mepivacaine Hydrochloride 
    * Scandicaine 
    * Polocaine 
    * Mepihexal 
    * Hexal Brand of Mepivacaine Hydrochloride 
 
MeSH Categories: 
 Chemicals and Drugs Category 
  Heterocyclic Compounds 
   Heterocyclic Compounds, 1-Ring 
    Piperidines 




Year Introduced: 1968 (1967) 
PubChem Compound;  CID 4906 
IUPAC: N-(2-methylphenyl)-2-propylaminopropanamide 
Entry Terms: 
    * Propitocaine 
    * Citanest 
    * Inibsa Brand of Prilocaine Hydrochloride 
    * Xylonest 
    * Astra Brand of Prilocaine Hydrochloride 
    * Prilocaine Hydrochloride 
    * Delvet Brand of Prilocaine Hydrochloride 
    * Parnell Brand of Prilocaine Hydrochloride 
    * Citanest Octapressin 
 
Previous Indexing:  Anesthetics, Local (1966) 
 
MeSH Categories: 
 Chemicals and Drugs Category 
  Organic Chemicals 
   Amides 
    Anilides 




Year Introduced: 1991 (1979) 




    * Carticain 
    * Articain 
    * Articaine 
    * Carticaine Hydrochloride 
    * Hydrochloride, Carticaine 
    * Hoe-40045 
    * Hoe 40045 
    * Hoe40045 
    * Hoe-045 
    * Hoe 045 
    * Septocaine 
    * Hoe045 
    * Ultracaine 
    * Hoechst Brand of Carticaine Hydrochloride 
 
Previous Indexing:  Thiophenes (1966-1978) 
 
MeSH Categories: 
 Chemicals and Drugs Category 
  Organic Chemicals 
   Sulfur Compounds 
    Thiophenes 





Year Introduced:  1973 (1971) 
PubChem Compound:  2474 
IUPAC: 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 
Entry Terms: 
    * 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide 
    * Bupivacain-RPR 
    * Bupivacain RPR 
    * Aventis Brand of Bupivacaine Hydrochloride 
    * Bupivacaina Braun 
    * Braun, Bupivacaina 
    * Braun Brand of Bupivacaine Hydrochloride 
    * Bupivacaine Anhydrous 
    * Anhydrous, Bupivacaine 
    * Svedocain Sin Vasoconstr 
    * Inibsa Brand of Bupivacaine Hydrochloride 
    * Bupivacaine Hydrochloride 
    * Hydrochloride, Bupivacaine 
    * Bupivacaine Monohydrochloride, Monohydrate 
    * Buvacaina 
    * Pisa Brand of Bupivacaine Hydrochloride 
    * Dolanaest 
    * Strathmann Brand of Bupivacaine Hydrochloride 
    * Sensorcaine 
    * Astra Brand of Bupivacaine Hydrochloride 
    * Marcaine 
    * Carbostesin 
    * Marcain 
    * Abbott Brand of Bupivacaine Hydrochloride 
    * AstraZeneca Brand of Bupivacaine Hydrochloride 
    * Bupivacain Janapharm 
    * Janapharm, Bupivacain 
    * Jenapharm Brand of Bupivacaine Hydrochloride 
    * Bupivacaine Carbonate 
    * Carbonate, Bupivacaine 
 
Previous Indexing:  Anesthetics, Local (1966-70) 
 
MeSH Categories: 
 Chemicals and Drugs Category 
  Organic Chemicals 
   Amides 
    Anilides 
     Bupivicaine 
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Appendix IV: 
Electronic Search Strategies-  
 
Database: Ovid MEDLINE(R) <1950 to May Week 5 2009> 
Search Strategy (Line-by-Line Version): 
--------------------------------------------------------
------
1     exp Anesthesia, Dental/ (9373) 
2     exp Anesthesia, Local/ (12671) 
3     exp Anesthetics, Local/ (78730) 
4     exp Nerve Block/ (12474) 
5     exp Anesthesia, Conduction/ 
(45033) 
6     ((local or infiltration or conduction 
or block) adj (anesthe: or 
anaesthe:)).mp. (26226) 
7     exp Dentistry/ (288524) 
8     exp Stomatognathic system/ 
(276423) 
9     exp Stomatognathic diseases/ 
(347974) 
10     or/7-9 (656226) 
11     or/2-5 (109061) 
12     11 and 10 (5616) 
13     1 or 12 (11864) 
14     exp Carticaine/ (263) 
15     septocaine.mp. (1) 
16     ultracaine.mp. (41) 
17     articain$2.mp. (183) 
18     carticain$2.mp. (294) 
19     (hoe-40045 or hoe40045 or "hoe 
40045" or hoe-045 or hoe045 or "hoe 
045").mp. (6) 
20     23964-57-0.rn. (263) 
21     "methyl 4-methyl-3-(2-
propylaminopropanoylamino)thiophene-
2-carboxylate".mp. (0) 
22     14 or 15 or 16 or 17 or 18 (323) 
23     Thiophenes/ (6945) 
24     22 or 23 (7209) 
25     exp Bupivacaine/ (8400) 
26     bupivacain$5.mp. (10330) 
27     svedocain$2.mp. (0) 
28     dolanaest.mp. (0) 
29     sensorcain$2.mp. (10) 
30     marcain$2.mp. (320) 
31     carbostesin.mp. (23) 
32     2180-92-9.rn. (8400) 
33     "1-butyl-n-(2,6-dimethylphenyl)-
2-piperidinecarboxamide".mp. (0) 
34     or/25-32 (10432) 
35     exp Lidocaine/ (19034) 
36     lidocain$2.mp. (22997) 
37     lignocaine.mp. (2261) 
38     octocaine.mp. (2) 
39     xylesthesin.mp. (0) 
40     xylocain$5.mp. (941) 
41     dalcaine.mp. (0) 
42     xylocitin.mp. (10) 
43     xyloneural.mp. (3) 
44     ("2-2etn-2mephacn" or "2 2etn 
2mephacn").mp. (0) 
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45     "2-(diethylamino)-n-(2,6-
dimethylphenyl)acetamide".mp. (2) 
46     137-58-6.rn. (19034) 
47     or/35-46 (23841) 
48     exp Mepivacaine/ (1661) 
49     mepivacain$2.mp. (2107) 
50     isocain$2.mp. (1) 
51     meaverin.mp. (2) 
52     mecain.mp. (0) 
53     scandonest.mp. (3) 
54     mepivastesin.mp. (0) 
55     scandinibsa.mp. (0) 
56     carbocain$2.mp. (109) 
57     scandicain$2.mp. (31) 
58     polocain$2.mp. (7) 
59     mepihexal.mp. (0) 
60     isogain$2.mp. (0) 
61     "N-(2,6-dimethylphenyl)-1-
methyl-2-Piperidinecarboxamide".mp. 
(0) 
62     "N-(2,6-dimethylphenyl)-1-
methyl-2-carboxamide".mp. (0) 
63     96-88-8.rn. (1661) 
64     or/48-63 (2156) 
65     exp Prilocaine/ (1692) 
66     prilocain$2.mp. (1955) 
67     propitocain$2.mp. (11) 
68     citanest.mp. (119) 
69     xylonest.mp. (17) 
70     "N-(2-methylphenyl)-2-
(propylamino)-Propanamide".mp. (0) 
71     721-50-6.rn. (1692) 
72     or/65-71 (2009) 
73     or/13,24,34,47,64,72 (51038) 
74     exp Endodontics/ (20525) 
75     exp Dental Pulp Diseases/ (7854) 
76     exp Periapical Diseases/ (5330) 
77     exp "Root Canal Filling Materials"/ 
(5154) 
78     Dental Pulp Test/ (821) 
79     Dental Pulp/ (8377) 
80     Dental Pulp Cavity/ (5108) 
81     or/74-80 (36956) 
82     "root canal".mp. (18594) 
83     apicectom:.mp. (200) 
84     apicoectom:.mp. (1354) 
85     (dead adj3 (teeth or tooth)).mp. 
(29) 
86     (dental adj3 pulp:).mp. (18570) 
87     endodont:.mp. (10745) 
88     endont:.mp. (15) 
89     endosonic.mp. (56) 
90     ((lateral or vertical) adj 
condensation).mp. (586) 
91     ((non-vital or nonvital) adj3 (teeth 
or tooth)).mp. (1081) 
92     obtura.mp. (77) 
93     obturation.mp. (4623) 
94     obturate.mp. (78) 
95     (pulp adj3 (capping or therap: or 
extirpation:)).mp. (1993) 
96     (pulp adj (canal$1 or 
chamber$1)).mp. (1106) 
97     pulpectomy.mp. (1032) 
98     pulpotomy.mp. (1181) 
99     replantation.mp. (6368) 
100     ("root" adj end adj5 fill:).mp. 
(264) 
101     ((silver or gutta) adj3 (percha or 
balata)).mp. (2486) 
102     (silver adj (cone$1 or 
point$1)).mp. (129) 
103     thermafil.mp. (143) 
104     trans-polyisoprene.mp. (8) 
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105     transpolyisoprene.mp. (1) 
106     ultrafil.mp. (41) 
107     (periradicular or radicular or 
periapical or apical).mp. (53250) 
108     exp tooth/ (56413) 
109     exp tooth components/ (45905) 
110     107 and (108 or 109) (6093) 
111     or/82-106,110 (43553) 
112     or/81,111 (46231) 
113     *Apicoectomy/ (647) 
114     *Dental Implantation, 
Endosseous, Endodontic/ (289) 
115     *Retrograde Obturation/ (546) 
116     *Tooth Replantation/ (1078) 
117     or/113-116 (2408) 
118     112 not 117 (43823) 
119     73 and 118 (735) 
120     limit 119 to (english language 
and humans) (422) 
121     from 120 keep 1-418 (422) 
122     from 121 keep 1-418 (422)
 
Prose Version 
(((exp Anesthesia, Dental/ OR exp Anesthesia, Local/ OR exp 
Anesthetics, Local/ OR exp Nerve Block/ OR exp Anesthesia, 
Conduction/) OR (((local or infiltration or conduction or block) adj 
(anesthe: or anaesthe:)).mp. AND (exp Dentistry/ OR exp Stomatognathic 
system/ OR exp Stomatognathic diseases/))) OR (exp Carticaine/ OR 
septocaine.mp. OR ultracaine.mp. OR articain$2.mp. OR carticain$2.mp. 
OR (hoe-40045 or hoe40045 or "hoe 40045" or hoe-045 or hoe045 or "hoe 
045").mp. OR 23964-57-0.rn. OR "methyl 
4-methyl-3-(2-propylaminopropanoylamino)thiophene-2-carboxylate".mp.) 
OR Thiophenes/ OR (exp Bupivacaine/ OR bupivacain$5.mp. OR 
svedocain$2.mp. OR dolanaest.mp. OR sensorcain$2.mp.  OR marcain$2.mp. 
OR carbostesin.mp. OR 2180-92-9.rn.)  OR (exp Lidocaine/ OR 
lidocain$2.mp. OR lignocaine.mp. OR octocaine.mp. OR xylesthesin.mp. 
OR xylocain$5.mp. OR dalcaine.mp. OR xylocitin.mp. OR xyloneural.mp. 
OR ("2-2etn-2mephacn" or "2 2etn 2mephacn").mp. OR 
"2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide".mp. OR 
137-58-6.rn.) OR (exp Mepivacaine/ OR mepivacain$2.mp. OR 
isocain$2.mp. OR meaverin.mp. OR mecain.mp. OR scandonest.mp. OR 
mepivastesin.mp. OR scandinibsa.mp. OR carbocain$2.mp. OR 
scandicain$2.mp. OR polocain$2.mp. OR mepihexal.mp. OR isogain$2.mp. 
OR "N-(2,6-dimethylphenyl)-1-methyl-2-Piperidinecarboxamide".mp. OR 
"N-(2,6-dimethylphenyl)-1-methyl-2-carboxamide".mp. OR 96-88-8.rn.) OR 
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(exp Prilocaine/ OR prilocain$2.mp. OR propitocain$2.mp. OR 
citanest.mp. OR xylonest.mp. OR 
"N-(2-methylphenyl)-2-(propylamino)-Propanamide".mp. OR 721-50-6.rn.) 
AND ((exp Endodontics/ OR exp Dental Pulp Diseases/ OR exp Periapical 
Diseases/ OR exp "Root Canal Filling Materials"/ OR Dental Pulp Test/ 
OR Dental Pulp/ OR Dental Pulp Cavity/) OR (("root canal".mp. OR 
apicectom:.mp. OR apicoectom:.mp. OR (dead adj3 (teeth or tooth)).mp. 
OR (dental adj3 pulp:).mp. OR endodont:.mp. OR endont:.mp. OR 
endosonic.mp. OR ((lateral or vertical) adj condensation).mp. OR 
((non-vital or nonvital) adj3 (teeth or tooth)).mp. OR obtura.mp. OR 
obturation.mp. OR obturate.mp. OR (pulp adj3 (capping or therap: or 
extirpation:)).mp. OR (pulp adj (canal$1 or chamber$1)).mp. OR 
pulpectomy.mp. OR pulpotomy.mp. OR replantation.mp. OR ("root" adj end 
adj5 fill:).mp. OR ((silver or gutta) adj3 (percha or balata)).mp. OR 
(silver adj (cone$1 or point$1)).mp. OR thermafil.mp. OR 
trans-polyisoprene.mp. OR transpolyisoprene.mp. OR ultrafil.mp.) OR 
((periradicular or radicular or periapical or apical).mp. AND (exp 
tooth/ OR exp tooth components/))) NOT (*Apicoectomy/ OR *Dental 
Implantation, Endosseous, Endodontic/ OR *Retrograde Obturation/ OR 




Database - Embase: 
Search Strategy 
----------------------------------------------------------- 
3. septocaine (26) 
6. ‘articaine’/exp OR articaine (614) 
7. ‘carticaine’/exp OR carticaine (608) 
8. ‘ultracaine’/exp OR ultracaine (604) 
11. ‘thiophene derivative’/de (4,308) 
12. #11 OR #8 OR #7 OR #6 OR #3 (4,914) 
14. ‘dentistry’/exp (86,832) 
16. ‘mouth’/exp OR mouth (618,775) 
17. #16 OR #14 (669,577) 
18. #17 AND #12 (174)
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Appendix V: 























-Glossary of Terms 
 
Anesthetic Success None or mild pain measured using 
standard or modified VAS during clinical 
instrumentation or measured by no 
response by the tooth to maximal 
stimulation (80 µA) on two or more 
consecutive tests with EPT. 
Anesthetic Failure A rating of greater than mild pain 
measured using a standard or modified 
VAS during clinical instrumentation or 
measured by never achieving a ‘non-
response’ to maximal stimulation to EPT 
stimulation. 
Normal Dental Pulp A clinical diagnostic category in which the 
pulp is symptom free and normally 
responsive to vitality testing 
Irreversible Pulpitis A clinical diagnosis based on subjective 
and objective findings indicating that the 
vital inflamed pulp is incapable of healing 
Analgesia Absence of sensibility to pain, designating 
particularly the relief of pain without loss 
of consciousness 
Anesthesia The loss of feeling or sensation as a result 
of an anesthetic agent to permit diagnostic 
and treatment procedures 
Paresthesia A sensation such as burning, prickling, or 
partial numbness caused by neural injury 
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